Blue-Ray Biotech laboratory equipment | Reviews from the international market 2023-2025

Blog July 16, 2025

High-quality biomedical equipment supplier Blue-Ray Biotech has received positive feedback from customers and partners in the global biomedical industry. Refer to these multifaceted reviews to help biomedical professionals better understand the potential of collaborating with Blue-Ray Biotech. 

Below is a summary of the feedback from customers and partners regarding Blue-Ray Biotech in the 2023-2025 period, including both positive opinions and areas for improvement, in key regions: developed Asia, Europe, and emerging Southeast Asia.

 

Reviews of Blue-Ray Biotech from customers and partners
Reviews of Blue-Ray Biotech from customers and partners

Blue-Ray Biotech in the developed Asian market

In Taiwan – Hometown of Blue-Ray Biotech

The brand has established a solid reputation. Many leading laboratories in Taiwan trust and use Blue-Ray equipment. For example, a researcher at Academia Sinica (Taiwan’s Academia Sinica) commented that the TurboCycler PCR machine is “easy to operate” and especially noted that “the high ramp rate helps reduce reaction running time,” which is very useful for molecular biology experiments. Major universities in Taiwan have also applied the EzScope 101 system for cell research and achieved promising results, showing that Blue-Ray products meet scientific expectations. In general, the positive feedback from the Taiwanese market confirms the high quality and reliability of the equipment, which is comparable to foreign brands. 

In South Korea and Japan

Blue-Ray Biotech is gradually penetrating these markets through distribution partners and participating in regional conferences and exhibitions. In 2025, the company held a distributor conference with the participation of partners from South Korea and Japan, demonstrating its commitment to expanding in these regions. Customers in these countries are considered quite discerning and loyal to traditional brands, so Blue-Ray’s brand recognition is still low and poses an initial challenge. Some laboratories in Japan were initially sceptical about the durability of equipment from a new supplier. However, these initial concerns were gradually alleviated when partners had real-world experiences: Blue-Ray’s equipment quality was “surprisingly good for the price,” with many innovative features on par with larger brands. The competitive pricing factor is a significant advantage in South Korea and Japan, where research budgets are always tightly monitored. According to feedback from some laboratories, purchasing Blue-Ray equipment helped them save 20-30% of costs compared to Western equipment, achieving equivalent results (source: internal report from distributor).

On the other hand, a noted limitation is that Blue-Ray’s technical support network in Japan/Korea is currently limited and primarily dependent on distributors. Customers expect the company to establish regional warranty centres for long-term peace of mind. Blue-Ray has been addressing this issue by strengthening local partner collaboration and training on-site engineers in these countries.

 

In the developed Asian markets, Blue-Ray Biotech receives positive reviews for its technological expertise, product features, and pricing, but faces challenges in brand building and local after-sales service. With a strategy focused on quality and customer satisfaction, the company is gradually winning the trust of advanced labs in South Korea and Japan while maintaining its strong position in the Taiwanese market.

Blue-Ray Biotech in the European market

From 2023 to 2025, Blue-Ray Biotech made a significant mark in Europe, particularly Germany and the United Kingdom. Its presence at international medical fairs and reputable distribution channels indicates increasing acceptance from European customers.

For German customers

Blue-Ray Biotech first participated in the MEDICA 2023 exhibition and will return for MEDICA 2024. Feedback from German customers has been very positive: according to a report from Blue-Ray, “the feedback from visitors at MEDICA 2024 was overwhelmingly positive” regarding the company’s products. European customers appreciate the design and quality of Blue-Ray’s equipment – many were impressed that every detail of the product is meticulously crafted, showing the manufacturer’s seriousness. After seeing the EzDecap lid opening machine in action, some customers decided to place an order on the spot, proving the attraction of this unique solution. New products such as the EzCube Fluorometer and TurboX 48 automated extraction system also attracted significant interest, showing that the German market is quite receptive to Blue-Ray’s latest technology.

For the UK

Blue-Ray Biotech has entered the market through professional distributors. For example, Thistle Scientific in the UK (a reputable scientific equipment supplier for universities and research institutes) has included Blue-Ray’s full product range in their catalogue. This reflects trust in Blue-Ray’s quality in the UK market – university laboratories and research centres in the UK can now easily purchase Blue-Ray equipment from official distribution channels. Initial feedback from some UK customers showed that they appreciated the creativity of the products (such as the 3-block design of TurboCycler 3 or the EzScope mini microscope). University labs in London and Oxford (through partners) expressed satisfaction with a new high-performance equipment option at a more affordable price than traditional brands. Importantly, Blue-Ray strongly focuses on customer service: the company established a service office in Slovakia (EU) in 2022 to quickly support European customers, gaining goodwill for its after-sales service.

Negative feedback and challenges

Naturally, as Blue-Ray Biotech is still a relatively new name in Europe, comparisons with long-established brands are inevitable. Some German customers were initially sceptical about the long-term durability of Taiwanese equipment compared to German or US-made machines. However, these concerns were gradually dispelled by real-world evidence. For example, a scientist at the CNRS research centre (France) had used the PCR TurboCycler 2 for over two years and commented that the device “is still working very well… has not required any maintenance yet,” while the price is “much cheaper than the famous competitors.” Such practical experiences regarding durability and performance have helped convince European customers that Blue-Ray’s quality is comparable to larger brands, despite being a newer name.

Another point to note is compliance with European regulations: Blue-Ray has quickly met the necessary CE and ISO standards, allowing its equipment to be imported and legally used in European labs. This has dispelled concerns about legal barriers. However, some UK/German customers have requested Blue-Ray to expand its local support network (e.g., having service engineers in each major country) to ensure rapid assistance when equipment encounters issues.

 

In general, in the European market, Blue-Ray Biotech has received positive feedback regarding the features and value of its products – many customers find the equipment “worth the money,” offering performance equivalent to larger brands but at a more affordable price. Meanwhile, the company is also listening to feedback to improve after-sales service and increase its presence to meet the high expectations of European customers.

Blue-Ray Biotech in emerging Southeast Asian markets

The emerging Southeast Asian market is an important target market for Blue-Ray Biotech, as the demand for modern laboratory equipment is skyrocketing. At the same time, budgets in these countries are typically more limited than in developed nations. In the 2023-2025 period, Blue-Ray has made encouraging progress in Vietnam, Thailand, Indonesia, and Malaysia while learning valuable lessons from customer feedback in these regions.

Vietnam

Through its partner Biogroup Vietnam, Blue-Ray Biotech has been in the market since 2017, earlier than many competitors. As a result, its equipment has been tested and proven in practical use in Vietnam. Feedback from molecular biology laboratories in the country shows high satisfaction with the stability and longevity of the equipment. Many Blue-Ray PCR machines installed from 2017–2018 are still running well, helping customers save on maintenance and replacement costs. This is particularly important for small private labs in Vietnam. Customers also rate the support service from Biogroup/Blue-Ray as fast, with spare parts readily available, giving them confidence in investing in a new equipment brand.

Regarding performance, Vietnamese researchers note that the Blue-Ray PCR machine provides reliable results comparable to US/German machines in routine applications (such as PCR for African swine fever detection, COVID-19 testing…), which has helped build trust in the Blue-Ray brand within the user community. Moreover, the price factor is frequently highlighted in feedback: many labs in Vietnam choose Blue-Ray simply because of its highly competitive pricing. As a representative from Biogroup shared, the price of Blue-Ray equipment “is suitable for private labs… and research, teaching labs,” helping many units access advanced technology at an affordable cost. Thanks to this strategy, Blue-Ray’s market share in PCR, spectroscopy, etc., in Vietnam is rising.

Thailand

Blue-Ray has partnered with distributor Bio-Active since around 2021–2022. Over the past two years, many hospital and university labs in Thailand have trialled Blue-Ray products (especially the PCR machines and electronic pipettes). According to feedback from the 2023 customer seminar in Bangkok, Thai users found the TurboCycler PCR machine to be “quiet and fast” compared to their old models, with the English interface being easy to use. Some private labs in Bangkok are very interested in the TurboQ qPCR machine because it is significantly cheaper than US models, promising quicker return on investment when implementing testing. However, the main challenge in Thailand is the competition from low-cost Chinese brands. Some customers compare Blue-Ray with Chinese equipment and expect Blue-Ray’s prices to be even more affordable. This feedback indicates that Blue-Ray needs a flexible pricing strategy in emerging markets to compete with low-cost players in the budget segment. Additionally, some Thai technicians suggested that user manuals should have a Thai translation to serve better users who are not fluent in English. This is a cultural detail that Blue-Ray can improve upon shortly.

Indonesia and Malaysia

Blue-Ray Biotech was introduced recently through Sciencewerke (a regional distributor). Initial feedback from key laboratories has been quite optimistic. In Indonesia, hospital testing centres in Jakarta have trialled the TurboCycler machine and found the PCR results stable, comparable to the Japanese machines they had, while saving approximately 30% on the cost. A representative from a medical laboratory in Bandung remarked that having the Blue-Ray option helped them “break free from reliance on a few traditional suppliers,” providing more autonomy in equipment procurement. In Malaysia, academic customers (e.g., the University of Malaya) also expressed interest in the EzScope live-cell system due to its compact size, which fits nicely in small lab spaces. A common positive aspect from the Indonesian/Malaysian markets is the price and quality: Blue-Ray equipment is seen as “value for money,” suitable for Southeast Asian budgets. However, a significant challenge here is building initial trust. Some customers remain cautious due to the limited reference information about the brand. There was an instance where a laboratory in Malaysia requested a demo unit for a period before making a purchase decision. Blue-Ray responded by working with Sciencewerke to bring the machine for on-site demonstrations, gradually convincing the customer through real-world experience. Additionally, shipping times from Taiwan to Southeast Asia sometimes take longer than expected due to customs procedures – this is a point customers hope the company can improve (e.g., by keeping some machines in stock at the distributor’s warehouse for faster delivery).

 

Overall, in the emerging Southeast Asian markets, positive feedback outweighs the negative. Customers view Blue-Ray Biotech as providing modern technology solutions that are well-suited to local needs at reasonable costs. Many small labs now can own high-quality PCR and DNA sequencing machines thanks to Blue-Ray’s pricing. However, regional challenges, such as language barriers (manuals should be localised), delivery times, and the need to increase brand promotion, were noted. This feedback is invaluable for Blue-Ray and its partners (like Biogroup Vietnam) to adjust marketing strategies and improve customer support, winning the trust of target markets.

Conclusion

Blue-Ray Biotech has emerged as a trusted partner providing high-quality lab equipment at competitive prices. Its solid technological capabilities and diverse product portfolio form the foundation for the company to conquer many customer segments – from research institutes and hospitals to pharmaceutical companies and private labs. The feedback from key markets in the 2023–2025 period shows that Blue-Ray’s reputation is increasingly being affirmed: customers highly value the equipment’s performance, durability, and innovation (these positive responses are very encouraging for marketing activities). In addition, Blue-Ray also listens to and addresses any dissatisfaction (regarding services, branding, etc.) to improve continuously. For Biogroup Vietnam, this detailed information will help build a highly applicable marketing and communication strategy, emphasising the strengths of Blue-Ray Biotech while addressing customer concerns with real-world evidence from various markets. With this approach, Biogroup can confidently introduce Blue-Ray Biotech as a reliable and effective solution for Vietnam’s scientific and healthcare community.

 

 Contact now for expert advice from Biogroup

 

References

  1. Biogroup Vietnam. (2024). Blue-Ray Biotech product brochure [Internal document].
  2.  Blue-Ray Biotech. (n.d.). Company profile. https://www.blue-raybio.com/ 
  3.  Labcompare. (n.d.). Blue-Ray Biotech product reviews. https://www.labcompare.com/ 
  4.  SelectScience. (n.d.). User reviews on Blue-Ray Biotech instruments. https://www.selectscience.net/ 
  5. LinkedIn. (n.d.). Customer feedback on Blue-Ray Biotech from industry events (2023 –2025). https://www.linkedin.com/